Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) EBT: 2011-2024

Historic EBT for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$68.4 million.

  • Abeona Therapeutics' EBT rose 32.74% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$70.9 million, marking a year-over-year increase of 21.65%. This contributed to the annual value of -$68.4 million for FY2024, which is 43.88% down from last year.
  • Per Abeona Therapeutics' latest filing, its EBT stood at -$68.4 million for FY2024, which was down 43.88% from -$47.6 million recorded in FY2023.
  • Abeona Therapeutics' 5-year EBT high stood at -$47.6 million for FY2023, and its period low was -$93.4 million during FY2021.
  • In the last 3 years, Abeona Therapeutics' EBT had a median value of -$51.7 million in 2022 and averaged -$55.9 million.
  • As far as peak fluctuations go, Abeona Therapeutics' EBT spiked by 44.71% in 2022, and later slumped by 43.88% in 2024.
  • Abeona Therapeutics' EBT (Yearly) stood at -$84.2 million in 2020, then fell by 10.91% to -$93.4 million in 2021, then skyrocketed by 44.71% to -$51.7 million in 2022, then grew by 7.93% to -$47.6 million in 2023, then crashed by 43.88% to -$68.4 million in 2024.